Quality of Friendships in Children With Neurofibromatosis: Relationship to Disease Severity
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Neurofibromatosis
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 61
- Locations
- 1
- Primary Endpoint
- Disease severity scale and Friendship Quality Questionnaire (FQQ)
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
The aim of this study is to determine if children with a higher disease severity have lower quality friendships than children who are less severely affected and children who are unaffected. Researchers will test the hypothesis that the quality of friendships is inversely related to their disease severity.
Specific Aims:
- To use the FQQ to determine if the quality of friendships in children with NF1 is lower than the quality of friendships in unaffected children.
- To use a disease severity scale and the FQQ to determine if children who are less severely affected have higher friendship qualities than children who are more severely affected.
Detailed Description
You (your) child will be asked to complete a short questionnaire (40 questions) about their relationship with their best friend. Doctors will review your (child's) medical chart to find out how severe the disease is, so that this may be compared to the answers you have (your child has) given on the friendship questionnaire. This is an Investigational Study. About 90-100 children and adolescents with NF-1 will be asked to take part in this study. All will be enrolled at M.D. Anderson.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with a clinical diagnosis of neurofibromatosis, type 1 (NF-1) who are between the ages of 8 and 18 years will be eligible. Patients must be English or Spanish speaking (test instrument will be translated into Spanish), and be able to read.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Disease severity scale and Friendship Quality Questionnaire (FQQ)
Time Frame: Questionnaire completion by patient and chart review by doctor for disease severity scoring.